ANI Pharmaceuticals, Inc. (ANIP)
ANIP Stock Price Chart
Explore ANI Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ANIP price movements and trends.
ANIP Company Profile
Discover essential business fundamentals and corporate details for ANI Pharmaceuticals, Inc. (ANIP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
5 May 2000
Employees
897.00
CEO
Nikhil Lalwani
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.
ANIP Financial Timeline
Browse a chronological timeline of ANI Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 7 May 2026
Upcoming earnings on 26 Feb 2026
Upcoming earnings on 14 Nov 2025
EPS estimate is $1.70.
Earnings released on 8 Aug 2025
EPS came in at $1.80 surpassing the estimated $1.38 by +30.43%, while revenue for the quarter reached $211.37M , beating expectations by +1.23%.
Earnings released on 9 May 2025
EPS came in at $1.70 surpassing the estimated $1.37 by +24.09%, while revenue for the quarter reached $197.12M , beating expectations by +4.44%.
Earnings released on 28 Feb 2025
EPS came in at $1.63 surpassing the estimated $1.41 by +15.60%, while revenue for the quarter reached $190.57M , beating expectations by +12.13%.
Earnings released on 8 Nov 2024
EPS came in at $1.34 surpassing the estimated $1.09 by +22.94%, while revenue for the quarter reached $148.33M , missing expectations by -15.30%.
Earnings released on 6 Aug 2024
EPS came in at $1.02 surpassing the estimated $0.93 by +9.68%, while revenue for the quarter reached $138.04M , beating expectations by +6.97%.
Earnings released on 10 May 2024
EPS came in at $1.21 surpassing the estimated $0.98 by +23.47%, while revenue for the quarter reached $137.43M , beating expectations by +9.49%.
Earnings released on 29 Feb 2024
EPS came in at $1.00 surpassing the estimated $0.80 by +25.00%, while revenue for the quarter reached $131.65M , beating expectations by +7.73%.
Earnings released on 8 Nov 2023
EPS came in at $1.27 surpassing the estimated $0.76 by +67.11%, while revenue for the quarter reached $131.83M , beating expectations by +7.84%.
Earnings released on 9 Aug 2023
EPS came in at $1.28 surpassing the estimated $0.64 by +100.00%, while revenue for the quarter reached $116.55M , beating expectations by +18.08%.
Earnings released on 8 May 2023
EPS came in at $1.17 surpassing the estimated $0.34 by +244.12%, while revenue for the quarter reached $106.79M , beating expectations by +27.90%.
Earnings released on 9 Mar 2023
EPS came in at $0.76 surpassing the estimated $0.68 by +11.76%, while revenue for the quarter reached $94.23M , beating expectations by +9.39%.
Earnings released on 9 Nov 2022
EPS came in at $0.64 surpassing the estimated $0.58 by +10.34%, while revenue for the quarter reached $83.82M , beating expectations by +6.97%.
Earnings released on 8 Aug 2022
EPS came in at $0.13 surpassing the estimated $0.12 by +8.33%, while revenue for the quarter reached $73.86M , beating expectations by +2.62%.
Earnings released on 10 May 2022
EPS came in at -$0.12 falling short of the estimated $0.08 by -250.00%, while revenue for the quarter reached $64.48M , missing expectations by -0.86%.
Earnings released on 15 Mar 2022
EPS came in at $0.54 falling short of the estimated $0.82 by -34.15%, while revenue for the quarter reached $60.93M , beating expectations by +8.22%.
Earnings released on 1 Nov 2021
EPS came in at $1.01 surpassing the estimated $0.71 by +42.25%, while revenue for the quarter reached $52.06M , beating expectations by +4.75%.
Earnings released on 6 Aug 2021
EPS came in at $0.67 surpassing the estimated $0.65 by +3.08%, while revenue for the quarter reached $48.63M , beating expectations by +1.20%.
Earnings released on 7 May 2021
EPS came in at $1.04 surpassing the estimated $0.73 by +42.47%, while revenue for the quarter reached $54.52M , beating expectations by +13.24%.
Earnings released on 9 Mar 2021
EPS came in at $0.80 falling short of the estimated $1.00 by -20.00%, while revenue for the quarter reached $57.25M .
Earnings released on 5 Nov 2020
EPS came in at $0.97 surpassing the estimated $0.92 by +5.43%, while revenue for the quarter reached $52.98M , beating expectations by +10.23%.
ANIP Stock Performance
Access detailed ANIP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.